Newest Assay Kits
To keep up with the speed of your innovation, we strive to provide tools designed to benefit your research. Every day, our R&D scientists are focused on developing fully validated, ready-to-use assay kits and reagents for the hottest new targets. We've added hundreds of new assay kits to our portfolio and plan on continuing to evolve our product selection as your science evolves.
The products below represent our new assay kits. Be sure to check back frequently as we continue to launch new assay kits.
Most recently released targets
| Inflammation | IL12p70 (mouse) | STAT1 Phospho-Y701/STAT2 Phospho-Y690 Complex | STAT2 Phospho-Y690, Total | ||
| Explore inflammation products | |||||
| Oncology | BCR-ABL1 Phsopho-Y245, Phospho-Y412, Total | EGF Receptor E746A-750 Deletion Total | EGR1 Total (Biotin Free) | FOXM1 Phospho-T600, Total | |
| H2AX Phospho-S139, Total (mouse) | HRAS Total | Ki-67 Total | NRAS Total | ||
| Src Total | |||||
| Explore oncology products | |||||
| Protein-Protein Interaction | FLAG Check Kit | ||||
NEW pHSense™ reagents for internalization studies
Discover a powerful new plate reader tool specifically designed for cell surface target internalization studies necessary for ADC and GPCR research.
pHSense probes are plate reader-compatible reagents with time-resolved fluorescence (TRF) readout specifically developed for internalization studies. This technology reinforces Revvity's commitment to advancing drug discovery workflows. pHSense offers:
- Higher throughput plate-based pH sensitive internalization reagents
- Superior signal-to-background for more reliable pharmacological data
- Versatility across suspension & adherent cells
Newest target videos
Discover brief animated videos providing information on specific targets and research areas that are addressed by our newly released assay kits!
Discover brief animated videos providing information on specific targets and research areas that are addressed by our newly released assay kits!
LRRK2 in Parkinson's disease
Key protein targets in TPD
Synthetic lethality in cancer
Aurora kinases in the cell cycle
The power of cytokines
Autophagy and its potential in therapeutics
HTT in Huntington’s disease pathology
AAVs as gene therapy vectors
Exploring Janus kinases
BRD proteins as therapeutic targets
LC3B: Key marker of autophagy
Targeting the ECM
How can we help you?
We are here to answer your questions.